−1.08CAD
−27.24 MCAD
14.04 M
About BRIACELL THERAPEUTICS CORP
Sector
Industry
CEO
William V. Williams
Website
Headquarters
West Vancouver
Employees (FY)
12
Founded
2006
ISIN
CA1079301091
FIGI
BBG0086KF7Y2
BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company, which engages in the development of immunotherapies for the treatment of cancer. Its technologies include Bria-IMT and Bria-OTS. The company was founded by Charles L. Wiseman and Isaac B. Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where BCT is featured.
Frequently Asked Questions
The current price of BCT is 3.95 CAD — it has increased by 2.60% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NEO exchange BRIACELL THERAPEUTICS CORP stocks are traded under the ticker BCT.
Yes, you can track BRIACELL THERAPEUTICS CORP financials in yearly and quarterly reports right on TradingView.
Like other stocks, BCT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BRIACELL THERAPEUTICS CORP stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 12.00 employees. See our rating of the largest employees — is BRIACELL THERAPEUTICS CORP on this list?